# Gut Microbiome and p-Inulin in CKD - TarGut CKD Study

> **NCT03348592** · NA · UNKNOWN · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 18 (estimated)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **DIETARY_SUPPLEMENT:** Oligofructose-enriched inulin (p-inulin)
- **OTHER:** No treatment

## Key facts

- **NCT ID:** NCT03348592
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2017-11
- **Final completion:** 2018-06
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2017-11-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03348592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03348592, "Gut Microbiome and p-Inulin in CKD - TarGut CKD Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03348592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*